Three clinical sites are now fully open; final three sites expected to open imminently ASHBURN, Va., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, has established a patient specific website: https://www.nethertonsyndromeclinicaltrials.com/, to facilitate… Read More..

New CEO brings 25 years’ experience and successful track record in neurological and neuropsychiatric drug development TORONTO, Ontario and CAMBRIDGE, Massachusetts , Sept. 13, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN) (TSX: PMN), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins… Read More..

Presentation on Monday, September 12th at 5:00pm ET September 12, 2022 08:00 AM Eastern Daylight Time DALLAS--(BUSINESS WIRE)--Blackboxstocks, Inc. (NASDAQ: BLBX), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, today announced that management will present at the H.C.… Read More..